Skip to main content

Table 6 Lactate, CRP, duration of MV, duration of vasopressor use, ICU stay and hospital stay data between the two groups

From: Role of dexmedetomidine in modifying immune paralysis in patients with septic shock: randomized controlled trial

 

Group D (n = 12)

Median (IQR)

Group M (n = 12)

Median (IQR)

P value

ANOVA

P value

Lactate 0 (mmole/l)

4.2 (3.12–5.5)

2.9 (2.4–3.9)

0.03

0.19

Lactate 6H (mmole/l)

2.3 (1.9–3.4)

2.3 (1.2–3.42)

0.8

 

Lactate 12H (mmole/l)

1.9 (1.3–2.9)

1.5 (1.1–2.2)

0.32

 

Lactate 24H (mmole/l)

1.4 (1.1–1.9)

1.15 (0.9–1.95)

0.97

 

CRP 0 (mg/l)

267.5 (130.5–333.7)

147.5 (174.2–318.2)

0.72

0.71

CRP day 1 (mg/l)

290.5 (210.2–348.7)

245 (172–283.5)

0.31

 

CRP Day 3 (mg/l)

188.5 (103–275.2)

203 (113.2–253.2)

0.68

 

CRP Day 5 (mg/l)

173 (112.2–224.5)

181 (98.5–196)

0.85

 

Duration of mechanical ventilation (days)

2.5 (1–3.75)

2 (1–6.75)

0.61

 

Duration of vasopressors (days)

2 (1.25–4.5)

2 (1–3.75)

0.84

 

ICU stay (days)

6.5 (5–7.75)

5.5 (5–8.5)

0.77

 

Hospital stay (days)

8 (7–10)

7.5 (6–9)

0.45

 
  1. Data are presented as the median (interquartile range)
  2. CRP C reactive protein